Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Boehringer Ingelheim, Gubra to develop anti-obesity peptide poly-agonists
Image: Boehringer Ingelheim and Gubra announce new collaboration to develop anti-obesity peptide poly-agonists. Photo: courtesy of Madras150/Wikimedia Commons.
Image: Boehringer Ingelheim and Gubra announce new collaboration to develop anti-obesity peptide poly-agonists. Photo: courtesy of Madras150/Wikimedia Commons.